Conservative treatment for infiltrating breast cancer: Ten years follow-up experience

Clinical and Translational Oncology

Volumn 8, Issue 9, 2006, Pages 672-675

  Mateos, Antonio Mena ^a,b   Villanueva, Augusto García ^a   Montes, Irene Moreno ^a   Guirao, Ma Vicenta Collado ^a   Blanco, Roberto Rojo ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NONE   (Spain)

Author keywords

Breast cancer; Conservative surgery; Lymphedema; Recurrence

Indexed keywords

HORMONE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER INFILTRATION; CANCER STAGING; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PATIENT SATISFACTION; PREMENOPAUSE; RECURRENT CANCER; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; SURVIVAL TIME; BREAST TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATHOLOGY; RADIATION DOSE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; PATIENT SATISFACTION; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750619274     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0037-5     Document Type: Article

References (24)

1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty year follow up of a randomized study comparing breast conserving surgery with radical mastectomy for breast cancer. N Engl J Med. 2002;347:1227-32.
2. Fisher B, Anderson S, Bryant J, et al. Twenty year follow up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41.
3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-8.
4. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection. J Surg Oncol. 1996;62:75-7.
5. Krag DN, Weaver DL, Alex JC, Faibank JT. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol. 1993;2: 335-40.
6. TNM Classification des tumeurs malignes. UICC. 4ème ed. Springer-Verlag, Genéve; 1988.
7. Pendlebury SC, Ivanov O, Renwick S, Stevens GN. Long-term review of a breast conservation series and patterns of care over 18 years. ANZ J Surg. 2003;73(8): 577-83.
8. Doyle T, Schultz DJ, Peters C, Harris E, Solin LJ. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Rad Oncol. 2001;51(1):74-84.
9. Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer. 2004;100(9):1823-32.
10. Ogawa Y, Nishioka A, Inomata T, et al. Conservation treatment intensified with an anti-estrogen agent and CAF chemotherapy for stage I and II breast cancer. Oncol Reports. 2000;7(3):479-84.
11. García-Villanueva A, Rojo-Blanco R, Collado-Guirao MV, Ferreiro-Pozuelo N, Samaranch-Palero N. Tratamiento quirúrgico conservador del cáncer infiltrante de mama, en régimen de cirugía mayor ambulatoria. Cir Esp. 2002;72(5):255-60.
12. Neff-Philip T, Bear-Harry D, Pierce-Catherine V, et al. Long-term results of breast conservation therapy for breast cancer. Ann Surg. 1996;223(6):709-17.
13. Wazer DE, Dipetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1992;10(5):356-63.
14. Chang HR. Surgical therapy of invasive breast cancer. In: Singletary SE, Robb GL editors. Advanced therapy of breast disease. Hamilton, Ontario: BC Decker Inc; 2000, p. 143-55.
15. Meric-Bernstam F: Breast conservStion in breast cancer: surgical and adjuvant considerations. Curr Opin Obstet Gynecol. 2004;16(1):31-6.
16. Voogd-Adri C, Nielsen-Maja, Peterse-Johannes L, et al. Differences in risk factors for local and distant recurrence after breast-conservating therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol. 2001;19(6):1668-97.
17. Asrari F, Gage I. Radiation therapy in management or breast cancer. Curr Opin Oncol. 1999;11(6):463-7.
18. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320;822-8.
19. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breast-conservating therapy in the management of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10:976-83.
20. Clemons M, Hamilton T, Mansi J, Lockwood G, Goss P. Management of recurrent locoregional breast cancer: Oncologist survey. Breast 2003;12:328-37.
21. Piñero-Madrona A, Salinas-Ramos J, Illana-Moreno J, Sola-Pérez J, Canteras-Jordana M. Locoreginal recurrence and metastasis in the long-term follow-up of postmastectomy breast cancer patients with T1-T2 tumours and one to three positive lymph nodes. Rev Oncol. 2004;6(6): 341-6.
22. Margolese RG, Lasry JC. Ambulatory surgery for breast cancer patients. Ann Surg Oncol. 2000;7:181-7.
23. Holcombe C, West N, Mansel RE, Horgan K. The satisfaction and savings of early discharge with drain in situ following axillary lymphadenectomy in the treatment of breast cancer. Eur J Surg Oncol. 1995; 21:604-6.
24. Dooley WC. Ambulatory breast cancer surgery. Ann Surg Oncol 2000;7:174-5.